Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Long-Term Debt Repayments (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Long-Term Debt Repayments over the past 16 years, most recently at $145.1 million for Q2 2025.

  • For Q2 2025, Long-Term Debt Repayments fell 0.8% year-over-year to $145.1 million; the TTM value through May 2025 reached $145.8 million, down 0.64%, while the annual FY2025 figure was $145.8 million, 0.64% down from the prior year.
  • Long-Term Debt Repayments for Q2 2025 was $145.1 million at Lifecore Biomedical, Inc. \De\, up from $313000.0 in the prior quarter.
  • Over five years, Long-Term Debt Repayments peaked at $146.2 million in Q2 2024 and troughed at -$29.5 million in Q4 2024.
  • A 5-year average of $35.1 million and a median of $313000.0 in 2025 define the central range for Long-Term Debt Repayments.
  • Biggest five-year swings in Long-Term Debt Repayments: surged 344160.0% in 2023 and later plummeted 15397.41% in 2024.
  • Year by year, Long-Term Debt Repayments stood at $38000.0 in 2021, then increased by 28.95% to $49000.0 in 2022, then soared by 293.88% to $193000.0 in 2023, then plummeted by 15397.41% to -$29.5 million in 2024, then surged by 591.33% to $145.1 million in 2025.
  • Business Quant data shows Long-Term Debt Repayments for LFCR at $145.1 million in Q2 2025, $313000.0 in Q1 2025, and -$29.5 million in Q4 2024.